NEKTAR THERAPEUTICS - NKTR
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | Chief R&D Officer | S | D | 180.0 | 73.0 | 13,140.0 | 21,174.0 | View | |
| Feb 20, 2026 | President & CEO | S | D | 423.0 | 73.0 | 30,879.0 | 75,489.0 | View | |
| Jan 22, 2026 | Chief R&D Officer | S | D | 3,867.0 | 35.67 | 137,935.89 | 21,354.0 | View | |
| Dec 23, 2025 | Chief R&D Officer | A | A | 25,000.0 | 0.0 | 0.0 | 25,000.0 | View | |
| Dec 23, 2025 | Chief R&D Officer | A | A | 6,250.0 | 0.0 | 0.0 | 25,221.0 | View | |
| Dec 23, 2025 | President & CEO | A | A | 86,667.0 | 0.0 | 0.0 | 86,667.0 | View | |
| Dec 23, 2025 | President & CEO | A | A | 21,667.0 | 0.0 | 0.0 | 75,912.0 | View | |
| Nov 25, 2025 | Chief Legal Officer | A | A | 3,400.0 | 0.0 | 0.0 | 3,400.0 | View | |
| Nov 25, 2025 | Chief Legal Officer | S | D | 630.0 | 54.28 | 34,196.4 | 21,585.0 | View | |
| Nov 25, 2025 | Chief Legal Officer | A | A | 1,903.0 | 0.0 | 0.0 | 22,215.0 | View | |
| Nov 25, 2025 | Chief R&D Officer | A | A | 4,766.0 | 0.0 | 0.0 | 4,766.0 | View | |
| Nov 25, 2025 | Chief R&D Officer | S | D | 1,157.0 | 54.28 | 62,801.96 | 18,971.0 | View | |
| Nov 25, 2025 | Chief R&D Officer | A | A | 2,666.0 | 0.0 | 0.0 | 20,128.0 | View | |
| Nov 25, 2025 | President & CEO | A | A | 12,170.0 | 0.0 | 0.0 | 12,170.0 | View | |
| Nov 25, 2025 | President & CEO | S | D | 2,207.0 | 54.28 | 119,795.96 | 54,245.0 | View | |
| Nov 25, 2025 | President & CEO | A | A | 7,110.0 | 0.0 | 0.0 | 56,452.0 | View |